UBS Group’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $217K | Sell |
51,606
-5,421
| -10% | -$22.8K | ﹤0.01% | 5428 |
|
2025
Q1 | $272K | Sell |
57,027
-11,588
| -17% | -$55.3K | ﹤0.01% | 5100 |
|
2024
Q4 | $261K | Buy |
68,615
+66,732
| +3,544% | +$254K | ﹤0.01% | 5103 |
|
2024
Q3 | $16.9K | Buy |
1,883
+1,676
| +810% | +$15K | ﹤0.01% | 6257 |
|
2024
Q2 | $2.01K | Buy |
207
+1
| +0.5% | +$10 | ﹤0.01% | 7276 |
|
2024
Q1 | $2.79K | Sell |
206
-2,752
| -93% | -$37.3K | ﹤0.01% | 6654 |
|
2023
Q4 | $32.4K | Buy |
2,958
+300
| +11% | +$3.29K | ﹤0.01% | 5598 |
|
2023
Q3 | $27.2K | Buy |
2,658
+497
| +23% | +$5.09K | ﹤0.01% | 5506 |
|
2023
Q2 | $34.1K | Buy |
2,161
+2,056
| +1,958% | +$32.4K | ﹤0.01% | 5597 |
|
2023
Q1 | $2.37K | Sell |
105
-505
| -83% | -$11.4K | ﹤0.01% | 7424 |
|
2022
Q4 | $21.8K | Buy |
610
+486
| +392% | +$17.4K | ﹤0.01% | 6387 |
|
2022
Q3 | $5K | Buy |
124
+86
| +226% | +$3.47K | ﹤0.01% | 8079 |
|
2022
Q2 | $2K | Hold |
38
| – | – | ﹤0.01% | 8487 |
|
2022
Q1 | $4K | Sell |
38
-4,762
| -99% | -$501K | ﹤0.01% | 8227 |
|
2021
Q4 | $1.07M | Buy |
4,800
+1,920
| +67% | +$426K | ﹤0.01% | 3397 |
|
2021
Q3 | $997K | Buy |
2,880
+2,304
| +400% | +$798K | ﹤0.01% | 3260 |
|
2021
Q2 | $217K | Sell |
576
-10,430
| -95% | -$3.93M | ﹤0.01% | 4265 |
|
2021
Q1 | $3.42M | Buy |
11,006
+6,450
| +142% | +$2M | ﹤0.01% | 2284 |
|
2020
Q4 | $1.14M | Sell |
4,556
-2,180
| -32% | -$545K | ﹤0.01% | 3053 |
|
2020
Q3 | $1.25M | Buy |
6,736
+6,283
| +1,387% | +$1.16M | ﹤0.01% | 2781 |
|
2020
Q2 | $114K | Sell |
453
-97
| -18% | -$24.4K | ﹤0.01% | 4383 |
|
2020
Q1 | $100K | Sell |
550
-823
| -60% | -$150K | ﹤0.01% | 4433 |
|
2019
Q4 | $572K | Buy |
1,373
+1,236
| +902% | +$515K | ﹤0.01% | 3789 |
|
2019
Q3 | $34K | Sell |
137
-1,956
| -93% | -$485K | ﹤0.01% | 5456 |
|
2019
Q2 | $832K | Buy |
2,093
+1,783
| +575% | +$709K | ﹤0.01% | 3174 |
|
2019
Q1 | $167K | Buy |
+310
| New | +$167K | ﹤0.01% | 3966 |
|